logo
Loading...

A Phase 3 Trial of a JAKi in Patients With Giant Cell Arteritis Sponsored by AbbVie Medical Affairs + Health Impact

logo

Rheumnow Podcast

Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses the latest results, including...

1 year ago
Album Cover
A Phase 3 Trial of a JAKi in Patients With Giant Cell Arteritis Sponsored by AbbVie Medical Affairs + Health Impact
Rheumnow Podcast
0:00 / 0:00

Read the original at soundcloud.com

Use this feed in your RSS reader

Copy the publisher’s public feed URL, or build an OPML reading list for another reader.

Open RSS feed · Find feeds & export OPML

Keep up with this source

Keep this source in your dashboard and return to its latest articles. Email alerts are managed separately in Settings.

FetchFeeds groups articles by feed so you can follow sources, compare coverage, and save stories for later.

Back to all articles from Rheumnow Podcast

More from this feed

Choose another story from Rheumnow Podcast.